Filing Details

Accession Number:
0001181431-14-023282
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-06-09 16:05:46
Reporting Period:
2014-05-30
Filing Date:
2014-06-09
Accepted Time:
2014-06-09 16:05:46
Original Submission Date:
2014-06-03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1053650 Omega Protein Corp OME Fats & Oils (2070) 760438393
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1029703 D John Held 2105 City West Boulevard
Suite 500
Houston TX 77042
Exec Vp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-30 14,443 $4.02 86,026 No 4 M Direct
Common Stock Disposition 2014-05-30 14,443 $14.48 71,583 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy) Disposition 2014-05-30 14,443 $0.00 14,443 $4.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,127 2010-02-03 2019-02-03 No 4 M Direct
Footnotes
  1. This report corrects a 50 share over-reporting error in Mr. Held's May 30, 2014 Form 4 resulting from an administrative error caused by Mr. Held's broker. Based on information provided by Mr. Held's broker, Mr. Held's May 30, 2014 Form 4 reported 14,493 shares of common stock sold and 14,493 stock options exercised. Due to broker error, each of these numbers was over-reported by 50 and should have been 14,443. This Form 4/A corrects this broker reported error and reports the 14,443 shares and options correctly.
  2. Stock Option exercised and shares sold automatically pursuant to Trading Plan (SEC Rule 10b5-1)
  3. Value represents transactions with a weighted average sales price ranging from $14.46 to $14.52.
  4. Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request.
  5. Vests in 1/3 increments commencing on the first anniversary of date of grant. The date of grant was 2/3/2009.